Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125832531 | 12583253 | 1 | I | 20160307 | 20160712 | 20160722 | 20160722 | EXP | GB-MHRA-EYC 00142118 | GB-TEVA-676970ACC | TEVA | 32.00 | YR | M | Y | 92.00000 | KG | 20160722 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125832531 | 12583253 | 1 | PS | DULOXETINE HYDROCHLORIDE. | DULOXETINE HYDROCHLORIDE | 1 | Oral | Y | U | 90783 | 60 | MG | |||||||
| 125832531 | 12583253 | 2 | C | DIHYDROCODEINE BITARTRATE | DIHYDROCODEINE BITARTRATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125832531 | 12583253 | 1 | Borderline personality disorder |
| 125832531 | 12583253 | 2 | Facial pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125832531 | 12583253 | DS |
| 125832531 | 12583253 | HO |
| 125832531 | 12583253 | LT |
| 125832531 | 12583253 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125832531 | 12583253 | Abdominal pain upper | |
| 125832531 | 12583253 | Abnormal dreams | |
| 125832531 | 12583253 | Affect lability | |
| 125832531 | 12583253 | Aggression | |
| 125832531 | 12583253 | Agitation | |
| 125832531 | 12583253 | Alcohol intolerance | |
| 125832531 | 12583253 | Alcoholism | |
| 125832531 | 12583253 | Anxiety disorder | |
| 125832531 | 12583253 | Aphonia | |
| 125832531 | 12583253 | Blood bilirubin increased | |
| 125832531 | 12583253 | Chromaturia | |
| 125832531 | 12583253 | Condition aggravated | |
| 125832531 | 12583253 | Confusional state | |
| 125832531 | 12583253 | Cough | |
| 125832531 | 12583253 | Crying | |
| 125832531 | 12583253 | Disturbance in attention | |
| 125832531 | 12583253 | Dry mouth | |
| 125832531 | 12583253 | Dysphonia | |
| 125832531 | 12583253 | Epistaxis | |
| 125832531 | 12583253 | Faeces pale | |
| 125832531 | 12583253 | Fatigue | |
| 125832531 | 12583253 | Gingival bleeding | |
| 125832531 | 12583253 | Headache | |
| 125832531 | 12583253 | Hyperhidrosis | |
| 125832531 | 12583253 | Hypnagogic hallucination | |
| 125832531 | 12583253 | Hypomania | |
| 125832531 | 12583253 | Impatience | |
| 125832531 | 12583253 | Impulsive behaviour | |
| 125832531 | 12583253 | Insomnia | |
| 125832531 | 12583253 | Intention tremor | |
| 125832531 | 12583253 | Jaundice | |
| 125832531 | 12583253 | Logorrhoea | |
| 125832531 | 12583253 | Loss of libido | |
| 125832531 | 12583253 | Mania | |
| 125832531 | 12583253 | Mental fatigue | |
| 125832531 | 12583253 | Micropenis | |
| 125832531 | 12583253 | Nasal dryness | |
| 125832531 | 12583253 | Pain in extremity | |
| 125832531 | 12583253 | Paraesthesia | |
| 125832531 | 12583253 | Parotid gland enlargement | |
| 125832531 | 12583253 | Peripheral swelling | |
| 125832531 | 12583253 | Personality change | |
| 125832531 | 12583253 | Salivary hypersecretion | |
| 125832531 | 12583253 | Suicidal ideation | |
| 125832531 | 12583253 | Tremor | |
| 125832531 | 12583253 | Urine odour abnormal | |
| 125832531 | 12583253 | Vomiting | |
| 125832531 | 12583253 | Vomiting projectile | |
| 125832531 | 12583253 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125832531 | 12583253 | 1 | 20160301 | 20160601 | 0 | |
| 125832531 | 12583253 | 2 | 20060101 | 0 |